Management of earlobe keloids is still controversial. Many different treatment modaliti es have been employe d; howevel; no single approach has been completely successf ul. We used combination therap y that included compression therapy, laser excision, and serial steroid injection, which has improved our therapeutic outcomes fo r earlobe keloids.
Introduction
Sca r form ation afte r cutaneous trauma, surg ical or otherwise , en compasses a broad spectru m, rangin g fro m norm al sca rs to hypertrophic scars to keloid s. The term keloid is deri ved from the Greek word cheloides, meanin g "c rab's claw," becau se of its lateral extensions, resembling the legs of a crab, growing into norm al tissue.I Keloid scars outgro w the limit s of the or iginal wound as a res ult of excessive collage n dep osition. Histolo gically, they are characteri zed by numerous fibroblasts and thick, glassy collage n bundl es arra nged haphazardly, with abundant mucin ous ground substance . Often ind istinct fro m hypertrophic sca rs histologicall y, keloids grow past the range of the wound scar (figure I), whereas hypert rophi c scars are a fibrobl astic proli feration within the confines of the orig inal wo und scar.
Many theorie s exis t to ex plai n thi s haph azard collage n depo sition in keloid scars. Th e sca rs essentially develop from an abnormality in the synthesis and degradation of coll agen (which may have a ge netic influence), incited by various tissue traum as, or may have an autoi mmune or inflammatory comp onent.
Earlobe keloids are more d ifficult to treat than those at other sites, with higher rates of failure and recurrence.! Numerou s therapeutic mod aliti es hav e been used to treat them , including intralesional steroid injec tion alone; surgica l ex cision alone; surgica l excision with skin grafting ; surge ry followed by radiation therapy ; radia tion therap y alone ; sys te mic dru g therapie s, including vitamin E, penicilla mine, colchicine s, thiotepa , and tetrahydro xyquinone; massage; silicone ge l sheeting ; intralesional interferon ; compress ion therap y; cryoth erap y; laser exc ision; electrod essication ; and topic al medi cati on s such as 5-fluorouracil or bleom ycin. Combination therapy appears to be the most effec tive treatment, although few studies have compared the various regim ens.' No study has proven the effectiveness of one therap y ove r another.' Furth erm ore , no matt er wh ich for m of treatm ent is instituted , the likelihood of keloid recurrence remains high . We currently employ a combined approach, using the CO 2 laser for excision, followed by serial postoperati ve steroid inj ecti ons. Th e goal of this study was to determine whether our co mbined approac h is a viable treatment modality for earlobe keloids.
Patients and methods
Patients. Our series includ es 6 patients over a 2-year period ( 1999-200 I). All 6 patient s had a history of earlobe piercing. Th e age range of our pati ents was IS to 33 yea rs (me an, 25 .6). Th ree patient s had had no previous surgical exc isions, 2 patient s had had two pre vious exc isions, and I patient had had one previous ex cision (none of these wa s per form ed at our institution). Three of the 6 patient s, therefore, present ed with a recurrent earlobe keloid after attempted surgica l extirpation; the remaining 3 had primary keloid s. All 3 patient s with recurrent keloid s had und ergo ne "cold stee l" surgical ex tirpation without adj unctive intralesional stero id injections .
Methods. We use a combination appro ach at our institution . We begin with a full-thickness excision that includes rem oval of the entire ear-piercing track from anterior to posterior ("dumbbell ex tirpation") , using the pulsed CO 2 laser (figure 2). After ex tirpatio n, ant eri or defects are closed prim aril y without ten sion, usin g 5/0 interrupt ed monofilam ent polyprop ylene sutures (Pro lene; Ethicon , Inc.) only ant eri orly; posterior defects are left to heal by seco ndary intenti on. Imm ed iately afte r ex tirpation, approxim ately 0.5 to 1.0 ml of triam cin olone 40 mg/ml is injected subcutaneo usly at the time of surgery; it is then repea ted eve ry 2 wee ks for a total of four inj ections, and then monthl y for six additional inj ections. Sutures are remove d on postoperative day 5. Pat ients initiate co mpression ear ring therap y daily once the pos terior defect has demonstrated gra nulation.
Results
To date, all 6 patients have com pleted the above surgical reg imen and adj unctive modal ities. Fo llow-up ranged from 4 to 6 yea rs. All patients tolerated the proced ure we ll, without complication . We have had no rec urre nces to date, and favorable cos me tic results (figure 3).
Discussion
Treatment "s uccess" needs to be better defined in terms of rec urrence and latency from treatme nt. Ke loids are know n to rec ur afte r man y yea rs, and earlobe ke loids have a higher rec urre nce rate than those at other anatomic sites.' It has therefore becom e ge nerally accep ted that keloid treatme nt co ntrol rates should be repo rted wit h a minimum 2-to 3year follow -up, and actuarial statistical repo rting of da ta is preferable.v" Prospecti ve studies with keloids have been difficult , however, as many pat ient s do not compl y with postoperative follow-up visits.' In fact, only one ra ndo mize d trial has been publ ished for earlobe keloids; it suggested that treatment with a co mbination of surgery an d rad ioth erapy is superior to the co mbinatio n of surgery and intra lesio nal stero id injec tion."
Anecd otally, Parlette and Hendrix rep orted their best res ults with surgic al excision preceded by a series of intralesional stero id inj ections (triamci nolone, 10 mg/ml every other week for four visits), fo llowed by a similar ser ies beginning 2 wee ks afte r surgery." T here is a reported rec urre nce rate of 80 % for keloids treated with primary surgical exc ision alone.FVarious techniqu es have been used , including core excision, I I prim ary excision with local advancement flaps, wide excision with hea ling by seco nda ry intent ion , and primary closure.
Early reports suggested that laser exc ision might have fewer recurrences. However, rece nt studies using CO 2 lasers, neodynium:YAG lasers, and argo n lasers report a rec urre nce rate of 37.5 to 100%. 12.13 Proponent s of the CO 2 laser exc ision techniqu e claim that the intrinsic propert ies of laser surgery, whic h slow fibrob last pro liferation, may be responsible for de lay ing or preve nting the recurrence of keloids . Th e CO 2 laser emits an invisible beam of light in the far-infrared spec trum at a wavelength of 10,600 nm . Wh en the beam is defocused and a bea m diameter of 2 mm occurs, soft tissue is vaporized , whereas in the foc used mode, with a 0.1 to 0.2-mm bea m, a "light scalpe l" res ults, with a potenti al for bloodless exc isional surgery. Ultr astructural studies have shown that the foc used CO, laser produces precise des truction, since therm al necrosis is only 30 to 50 urn deep ; thus, the potent ial for co llateral thermal inju ry and subseq uent keloid formation is minimized." Kantor et al reported goo d res ults with the CO 2 laser exc ision of ea rlobe keloids in 16 patients du ring a postoperative fo llow-up interval ranging fro m 2 to 40 mon ths.':' However, hypertrophi c scarring occ urred in 4 of 16 patients (25 %) in the ir study. So me authors suggest that these hypertrophic sca rs may, in fact, be ea rly recurrent keloids. !' Furthermore, a prospective study by Stern and Lucente " reported a 70 % recurrence rate of ea rlobe keloids after CO 2 laser excision; however, the authors ack now ledge d that none oft he ir pati ent s was wh ite (w hites ge nera lly have a lower rate of co llage n synthesis than blacks), and their study population was fairly noncompliant with postoperative adjunctive tria mcinolone injections.
The co mbination of surgical exc ision, either co ld stee l or laser excision, followe d by postoperative intralesional stero id therap y, has dimini shed the reported recur rence rate to less than 50%.15Therefore, although intralesional cort icostero ids do not era dicate keloids, they ca n diminish pruritis and pain and ca n soften the lesions. Th ey are believed to act by inhibiting fibrobl ast grow th and decreasi ng alpha-2-macroglobulin levels, lead ing to co llage n degradation . Various cor ticos tero id pre para tio ns have been used (fro m hydrocort isone to dexameth asone to triamcin olone), with fair ly equal efficacy.'
Radiotherapy has also been used as an adjunctive treatment to surg ical excision for keloids . Rad ioth erapy acts by destroying the proli ferating fibro blast and neovascul ar buds, res ulting in dec rease d coll age n production . Th e timing of radia tio n administration (within I week after exc ision) and total dose give n (700 to 1,500 rad) appea r to be imp ortant variables in redu cing keloid rec urrence. 16 96 With adjuva nt postoperat ive radiatio n therapy, co ntro l rates are 70 to 90 %.1 7
In a rando mized, prospecti ve trial of ea rlo be keloids, Scl afan i et al dem on strated that surgery followed by radiation showed a tre nd toward lower keloi d recurrence rates ( 12.5%) than did surgery with postoperati ve steroid injections (33%).8Although no statistically significant difference was found between the two gro ups, the autho rs believed that postoperative radiation therapy was more effective than intralesional steroi d injection as an adj unct to surgical ex tirpa tion, espec ially in the noncompli ant patient.
Many physician s are relu ctant to treat a ben ign disease such as keloids with rad ioth erapy, citing the potential risk of radiation-induce d malignan cy. However, several studies with long-term follow-up have not rep orted any patients with postradiation carci nogenesis.I'':"
Various other adj unctive modalit ies have also been studied, such as silico ne gel sheeting, topical therap ies, sys temic therapies, and co mpress ion therapy. Most of these are anecdo tal reports." Silicone ge l shee ting has been show n to decrease pruri tis and pain of sca rs while increa sing scar pliab ility, theoreticall y by maint ainin g scar hydrat ion and ultimately dec reas ing proi nflammatory cy tok ine prol iferation and co llage n dep osition ; sca r elevation and pigm ent ation usually remain unchanged, however. With this modality, silico ne gel sheeti ng is applied for at least 12 hours daily. On e study showed that 79% of rev ised keloid scars treated with silicone gel shee ting had had no recurrence by 6 months postsurgery."
Co mpress ion therapy is anot her adjunct ive therapy for earlobe keloid regression . Itis believed that co nstant pressure grea ter than ca pillary pressure (24 mm Hg) decreases soft-tissue cellularity, increases interstitial space , and causes co llage n bundles to be more wide ly dispersed.
Cryo thera py has also been reported as an adj unct to enha nce the efficac y of the intral esional cor ticos tero ids after surgical excision of keloid s. Th is tech nique uses a refrigerant to indu ce ce ll and microcircul atory dam age, lead ing to tissue necrosis and sloughi ng. It appears to imp rove retention of the cort icostero id in the keloid when performed imm edi ately before injection , in addition to improving patient tolerance and overall keloid regression.
Regardless ofthe excisional technique emp loye d, proper surg ica l technique during keloid exc ision is imperati ve and may reduce kelo id recur rence. Coll ateral traum a to the wound bed must be min imized . Instrument s that do not crush the tissue shou ld be used . Tension-free closures are esse ntial, and absorbable sutures sho uld be avo ided. Furth ermore, although most surgeons recommend removing eve ry ves tige of the keloid, includ ing the core in a dumbbell-shaped ke loid, so me believe that leaving a rim of keloid intact may reduce subsequent tiss ue respo nse."
In co nclusion, our approach to treating ea rlobe kelo ids uses a combinatio n of three treatm ent modalities: laser surgica l excision, steroid inject ion, and mechan ical co mpre ssio n therapy. Thi s techni que targets the for mation of the ea rlobe keloid at num erou s sites in the proposed theoret ic path ogenesis by minimi zing co llatera l tissue traum a and targe ting local cutaneo us immune/inflammatory responses, as well as targeting co llagen deposition in an orga nized fashion with mechanical pressure therapy. These thr ee treatm ent modal ities allow for synergism of this mult imodality therapy.
Although our population size is quite small and has a follow-up latency ofle ss than 6 year s, we fee l our combination of tec hniques for trea ting earlobekeloids demonstrates a lower recurrence rate than that previously reported in the literatur e, with cosmetica lly favorable results and limited side effects or com plications.
We rea lize that keloids can recur after many years, and that most plastic surgeons are now reporting keloid treat me nt co ntro l rates after a follow-up of 3 years minimum. Th e transient natu re of our patient popul ation lim its ex tensive, long-term follow-up ; however, our series to date cer tainly co nfor ms to this standard.
Long-term follow-up and prospective, cont rolled studies are necessary to adequately co mpare the efficacy of our treatm ent ap pro ach with others for this difficul t-to-treat clinical entity.
